Company / Cash per Share
Kymera Therapeutics, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$5.50
FY2025
5-year range
$0.70 / $5.50
FY2021-FY2025
Trend
+154.3%
vs FY2024
Sector context
#38 of 205
Health Care
What the data says
Kymera Therapeutics, Inc.'s cash per share of $5.50 is higher than 81% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 7 years, ranging from $0.70 in FY2021 to $44.75 in FY2019.
Based on SEC 10-K filings.
5.50 in FY2025 with a 5-year CAGR of -32.5%. Top quartile in the Health Care sector.
Improved from $2.29 to $5.50 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +60.6%
- 5-Year CAGR
- -32.5%
- 10-Year CAGR
- -
Sector benchmark
-91.9% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 154.3% year-over-year.
- Ranks #38 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.50 | +154.3% |
| FY2024 | $2.16 | -5.6% |
| FY2023 | $2.29 | +72.7% |
| FY2022 | $1.33 | +90.4% |
| FY2021 | $0.70 | -98.2% |
| FY2020 | $39.40 | -12.0% |
| FY2019 | $44.75 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026